Chemo +/- INCB161734 in previously untreated KRAS G12D mutated metastatic pancreatic adenocarcinom

A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma

Disease Types: Pancreatic

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma 

For More Information:

https://clinicaltrials.gov/study/NCT07522073?term=INCB161734&viewType=Card&rank=3